DAY CORPORATION – Trademark Portfolio

Entity Type: 03

DAY CORPORATION holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 27 (Floor Coverings) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include BIOMOR, FLAVAY, PROVINE, RESIVIT, and DOCTORCEUTICALS. The owner is based in DAYTON, OH.

333 W. FIRST ST.

DAYTON, OH 45402

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

DAY CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

27
Floor Coverings (1 filing)

Carpets, rugs, mats and matting, linoleum and other materials for covering floors

Frequently Asked Questions

How many trademarks does DAY CORPORATION have?

DAY CORPORATION has 8 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 abandoned, 1 cancelled.

What trademark classes does DAY CORPORATION file in?

DAY CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 27 (Floor Coverings). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are DAY CORPORATION's most well-known trademarks?

DAY CORPORATION's registered trademark portfolio includes well-known marks such as BIOMOR, FLAVAY, PROVINE, RESIVIT, and DOCTORCEUTICALS. These are among 5 currently registered trademarks in the portfolio.

What is DAY CORPORATION's trademark registration success rate?

DAY CORPORATION has a 63% trademark registration rate, with 5 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.